Search

Search Constraints

You searched for: Author/Creator Won, Minhee

Search Results

11. Long-Term Report of a Comprehensive Molecular and Genomic Analysis in NRG Oncology/RTOG 0424: A Phase II Study of Radiation and Temozolomide in High-Risk Grade II Glioma. (2021)

12. Low-risk meningioma: Initial outcomes from NRG Oncology/RTOG 0539. Issue 1 (3rd June 2022)

13. NCOG-12. COGNITIVE FUNCTION (CF) & QUALITY OF LIFE (QOL) IN PATIENTS TREATED WITH PROCARBAZINE, CCNU, & VINCRISTINE (PCV) + RADIOTHERAPY (RT) VS. RT FOR ANAPLASTIC OLIGODENDROGLIOMA (AO) ON NRG RTOG TRIAL 9402. (12th November 2021)

14. Neurocognitive, symptom, and health-related quality of life outcomes of a randomized trial of bevacizumab for newly diagnosed glioblastoma (NRG/RTOG 0825). Issue 7 (30th January 2021)

15. Phase 2 trial of dasatinib in target-selected patients with recurrent glioblastoma (RTOG 0627). Issue 7 (10th March 2015)

16. Short delay in initiation of radiotherapy for patients with glioblastoma-effect of concurrent chemotherapy: a secondary analysis from the NRG Oncology/Radiation Therapy Oncology Group database. Issue 7 (15th February 2018)